| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,435 |
2,300 |
$128K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,779 |
1,773 |
$112K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,055 |
1,019 |
$70K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
653 |
650 |
$58K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
763 |
738 |
$21K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
137 |
135 |
$13K |
| 87428 |
|
330 |
327 |
$9K |
| 99058 |
|
127 |
122 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
462 |
453 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
68 |
68 |
$3K |
| 99000 |
|
382 |
351 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
63 |
60 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
355 |
348 |
$2K |
| S9083 |
Global fee urgent care centers |
14 |
12 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
29 |
26 |
$476.24 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13 |
12 |
$274.20 |
| 81002 |
|
158 |
158 |
$222.72 |
| 87807 |
|
15 |
14 |
$108.50 |
| 81025 |
|
12 |
12 |
$42.78 |
| 99051 |
|
1,620 |
1,562 |
$5.00 |
| 99072 |
|
20 |
19 |
$0.00 |
| 99001 |
|
15 |
15 |
$0.00 |
| 94760 |
|
17 |
16 |
$0.00 |